That's right, four Geron execs split $600,00 in cash bonuses. Geron in November said it would cut 66 jobs and halt its stem cells R&D program to concentrate on its portfolio of experimental cancer treatments. It's a little upsetting, bonuses for the top execs, while cutting jobs and halting its stem cell program. It's not like David Greenwood who makes $618,000 a year needs a $235,800 bonus or Dr. Stephen Kelsey who makes $595,000 a year and his bonus was $156,600. Melissa Kelly Behrs bonus was $107,500 and Jane Lebkowski received $107,200. I think stock options, based performce, are the right type of bonuses. No product or money coming in, no bonuses simple.
I sold 900 shares at $1.42, made a little money. The high for the week was $1.51 on Monday Dec. 19th and the low was $1.35 on Wednesday Dec. 21st. The avg. five day volume was 1,601,720 shares the three month avg was 1,543,410. Maybe we are at the bottom. If the volume and price start to slowly move up we should hit $2.00 by the end of Feb 2012.
Geron this month started two Phase II trials one evaluating its drug GRN1005 in lung ccancer that has spread to the brain. The other using the same drug to treat breast cancer that has spread to the brain. Results some time early in 2013.
Good luck in this rigged casino,
No comments:
Post a Comment